FROM PUBLIC EVENTS · 2026-11-15

Current stage

  1. Discovery · preclinical
  2. Early clinical · first deals
  3. Late clinical · capacity
  4. Commercial · sales
  1. Global approvals · expansion
  2. M&A · integration
  3. Pipeline reshaping

Late clinical · capacity Non-clinical orders from US and European customers have risen sharply, taking its order backlog to KRW 60.7 billion. Also seen: Global approvals · expansion

  • Report on an order backlog of KRW 60.7 billion and its push into the US and Europe. Source

Roles often seen at this stageResearch & development · Quality QA & QC · BD & licensing

Companies at the same stage and their people flow →

← Company library
Korea / Company briefSources checked 2026-11-15

Biotoxtech

A contract non-clinical testing company, including toxicology, increasing non-clinical orders for advanced medicines from US and European customers.

Non-clinical testing services

Service

Non-clinical studies from small molecules to ADCs, ASOs and gene therapies.

Official role guide

Biotoxtech careers

Current availability unconfirmed

Observed 2026-11-15

Work
Unconfirmed — The official careers page could not be confirmed.
Experience & requirements
Unconfirmed — The official careers page could not be confirmed.

Information from a role guide does not establish a current vacancy.

Sources & coverage 1

A brief based on selected official material, not an exhaustive product or vacancy list.

  1. 수주잔고 607억 쌓은 바이오톡스텍…미국·유럽 공략 '속도' ↗머니투데이 · Published 2026-10-13 · Sources checked 2026-11-15 · Original unavailable